Cospower Engineering Ratios

Cospower Engineering Ltd Ratios

The Cospower Engineering Ltd Ratios page provides a complete fundamental analysis of Cospower Engineering Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Cospower Engineering Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Cospower Engineering Ltd (NSE: , BSE: 543172) is currently trading at ₹902.50, with a market capitalization of ₹1.51B. As a major player in the Producer manufacturing sector and Electrical products industry, Cospower Engineering Ltd remains a key stock for fundamental analysis using Cospower Engineering Ltd Ratios.

Cospower Engineering Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Cospower Engineering Ltd P/E ratio currently stands at 74.44, making it one of the most tracked metrics in Cospower Engineering Ltd Ratios.

Historically, the Cospower Engineering Ltd P/E ratio has shown strong fluctuations:

• 2024: 74.44
• 2023: 297.92
• 2022: 216.97
• 2021: 13.56
• 2020: 10.10

The decline in Cospower Engineering Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Cospower Engineering Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 7.

Historical P/B trend:

• 2024: 7
• 2023: 4.74
• 2022: 6.36
• 2021: 1.47

Cospower Engineering Ltd is trading at a premium to its book value, indicating strong market confidence.

Price to Sales Ratio (P/S)

The Cospower Engineering Ltd P/S ratio currently stands at 4.12, an important part of Cospower Engineering Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 4.12
• 2023: 1.53
• 2022: 3.21
• 2021: 0.84

The rising Cospower Engineering Ltd P/S ratio indicates improved revenue valuation by investors.

Cospower Engineering Ltd Price to Cash Flow Ratio (P/CF)

The Cospower Engineering Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 156.74.

Historical Cospower Engineering Ltd Price to Cash Flow Ratio:

• 2024: 156.74
• 2023: 62.61
• 2022: 0
• 2021: 0
• 2020: 0

The rising Cospower Engineering Ltd Price to Cash Flow Ratio indicates premium valuation based on cash flow.

Cospower Engineering Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Cospower Engineering Ltd EV currently stands at ₹1.24B, representing the total company valuation including debt.

Historical EV trend:

• 2024: 1.24B
• 2023: 535.29M
• 2022: 624.87M
• 2021: 204.41M

Cospower Engineering Ltd enterprise value shows long-term growth, reflecting expansion and market confidence.

EV/EBITDA Ratio

The Cospower Engineering Ltd EV/EBITDA ratio is currently 20.74, a key metric in Cospower Engineering Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 20.74
• 2023: 16.34
• 2022: 63.08
• 2021: 10.71

Higher Cospower Engineering Ltd EV/EBITDA suggests premium valuation.

Cospower Engineering Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Cospower Engineering Ltd D/E ratio is currently 1, reflecting leverage and financial stability.

Historical D/E:

• 2024: 1
• 2023: 2.71
• 2022: 2.47
• 2021: 1.50

Higher D/E ratio indicates rising financial risk.

Return on Equity (ROE %)

The Cospower Engineering Ltd ROE currently stands at 12.07%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 12.07
• 2023: 1.60
• 2022: 2.97
• 2021: 11.31

Cospower Engineering Ltd maintains stable profitability levels.

Cospower Engineering Ltd Ratios Analysis Summary

The Cospower Engineering Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Cospower Engineering Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Cospower Engineering Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.